Article
The Complexities Surrounding GLP-1 Agonist Drugs
The rapidly evolving landscape of GLP-1s for weight management is prompting employers to reassess obesity strategies. Addressing the obesity epidemic requires long-term investment and societal change. Insurance coverage for obesity drugs must balance health benefits with financial considerations.
